36687-82-8 Usage
Description
L-carnitine is a naturally occurring amino acid derivative which is used as a weight loss supplement. L-carnitine-L-tartrate (LCLT) is the salt of L-carnitine with tartaric acid.? LCLT has potential chemoprotective and antioxidant activities
LCLT is used in foods as a source of L-carnitine for particular nutritional uses. It can be used to reduce soreness, improve oxygen flow, increase density of androgen receptors, and elevate post-exercise fat oxidation. LCLT also promotes human hair growth. LCLT is used as nutritional therapy in the treatment of fatty liver and hemorrhagic shock in pharmaceutical and as a nutritional supplement in agriculture/animal feed to increase the growth rate and reduce the fat rate of aquatic animal.
References
[1] https://www.cancer.gov
[2] https://supplementreviews.com
[3] https://www.oxfordbiolabs.com
Chemical Properties
Crystalline powder
Uses
L-Carnitine L-tartrate is used in pharma and food application as dietary supplement. It founds as well an application in cosmetics.
Check Digit Verification of cas no
The CAS Registry Mumber 36687-82-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,6,8 and 7 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 36687-82:
(7*3)+(6*6)+(5*6)+(4*8)+(3*7)+(2*8)+(1*2)=158
158 % 10 = 8
So 36687-82-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H19NO8/c1-12(2,3)5-6(4-7(13)14)20-11(19)9(16)8(15)10(17)18/h6,8-9,15-16H,4-5H2,1-3H3,(H-,13,14,17,18)/p-1/t6-,8?,9?/m0/s1
36687-82-8Relevant articles and documents
METHOD OF PRODUCING THERAPEUTIC AGENT
-
Paragraph 0009; 0012, (2014/10/29)
A method for producing a therapeutic agent and the agent thus produced. This therapeutic agent, referred to as D-boramine, has the following chemical formula:[(CH3)3NCH2CHOHCH2CO2H]2[O2CCHOHCHOHCO2] and has the following empirical formula: C18H36N2O12. The D-boramine is produced by allowing a reaction between approximately 500 mg of L-carnitine and approximately 2.5 mg of pyridoxal 5 phosphate in the presence of approximately 10 mg of fumaric acid. The reaction creates the D-boramine molecule as the reaction product. The D-boramine molecule has an orthorhombic crystalline structure and has been shown to be useful as a therapeutic agent in treating a variety of human cancers, ailments and diseases.
